B6.129-Mecp2^tm1.1Hupp/J

Stock number: 019528
Product name: Mecp2^R168X knock-in mice
Research areas: Neurobiology Research, Research Tools

Description

This strain is currently unavailable due to replenishing of cryopreserved stocks. Interested customers who register interest will be contacted when the strain is again available.

Mecp2^R168X knock-in mice develop impaired motor function, and behavioral abnormalities such as reduced anxiety. This strain may be useful for in studies of Rett syndrome.

Detailed description

The nonsense R168X mutation is one of the most common MeCP2 mutations associated with Rett syndrome (RTT), and produces a truncated mutant protein. These mice carry the R168X knock-in mutation of the Mecp2. An in-frame UGA stop codon is introduced with the adenine at position 502 substituted with thymine in exon 4. While gene transcript is detected by RT-PCR in total RNA from brain tissue of mutant male mice, no full length or truncated protein is detected in nuclear extracts from brain tissue of hemizygous males. Sequencing confirmed the presence of the mutation. Hemizygous males are smaller than wildtype littermates and exhibit tremors, hind limb clasping, hypoactivity, irregular breathing, and apnea as early as 27 days of age. Impaired motor performance and decreased anxiety-like behavior of hemizygous males are observed by 6 weeks of age. Heterozygous females start to develop tremor and hind limb clasping as early as 36 days. By 9 months of age, female heterozygotes exhibit impaired motor control. Mutant mice have poor nest building abilities. Hemizygous males have a median lifespan of 57 days of age, and lifespan range of 23 to 150 days.

Development

A targeting vector containing a FRT site flanked NEO cassette was used to insert the R168X point mutation (502 A to T) into exon 4. The construct was electroporated into 129 derived R1 embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6 blastocysts. The resulting chimeric males were bred to C57BL/6 females. Heterozygous female mice were were bred to 129S4/SvJaeSor-Gt(ROSA)26Sor^tm1(FLP1)Dym/J (Stock No. 003946) male mice to remove the FRT site flanked NEO cassette. The mice were then backcrossed to C57BL/6JRj (JANVIER LABS) for 10 generations. Upon arrival at The Jackson Laboratory, the mice were crossed to C57BL/6J inbred mice (Stock No. 000664) at least once to establish the colony.

Allele

Symbol: Mecp2^tm1.1Hupp
Name: targeted mutation 1.1, Peter Huppke
MGI accession ID: MGI:6392789
Generation method: Targeted
Attributes: Humanized sequence
Marker symbol: Mecp2
Marker name: methyl CpG binding protein 2
Chromosome: X
Strain of origin: (129X1/SvJ x 129S1/Sv)F1-Kitl⁺
Molecular note: A targeting vector containing an FRT flanked neomycin cassette was used to insert an in-frame UGA stop codon in place of the codon (AGA) for arginine (R168X) at position 502 in exon 4. R168X is the most common nonsense mutation associated with Rhett syndrome. Flp-mediated recombination removed the FRT-flanked neo cassette.